<?xml version="1.0" encoding="UTF-8"?>
<p>TB vaccine discovery is in an early stage, lagging drug discovery efforts by at least 10 years. Accordingly, the BMGF is putting increased focused on the upstream space with the intent of learning more about 
 <italic>Mtb</italic> pathogenesis, and the immune responses necessary to control TB disease and prevent established 
 <italic>Mtb</italic> infection. This information will help guide more rational and efficient TB vaccine development in the future.
</p>
